Predicting outcomes in patients with obstructive sleep apnea using hypoglossal nerve stimulation
Official title: Assessing Stimulated Upper Airway Mechanics to Predict Outcomes in Hypoglossal Nerve
Run by Johns Hopkins University · NCT05429983 · Data updated 2026-11-12
This study is trying to figure out how the upper airway works in people with obstructive sleep apnea to see why some don’t respond well to a specific treatment called hypoglossal nerve stimulation.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Johns Hopkins University Academic / other |
| Locations | 1 site (Baltimore, Maryland) |
| Status | Recruiting |
| Started | November 29, 2022 |
| Main results expected | November 29, 2027 |
| Study ends | November 29, 2028 |
| Registry record updated | December 24, 2025 |
| Trial ID | NCT05429983 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are males and females with moderate to severe obstructive sleep apnea who are undergoing DISE for HGNS evaluation.
✕Probably not a fit
Patients with significant cardiac, pulmonary, liver, or renal diseases, uncontrolled hypertension, neuromuscular diseases, major psychiatric disorders, or those who are pregnant or on anticoagulation therapy may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to characterize upper airway biomechanics and identify predictors of clinical responses to hypoglossal nerve stimulation (HGNS) therapy in patients with obstructive sleep apnea (OSA). Participants will include individuals undergoing drug-induced sleep endoscopy (DISE) as part of their evaluation for HGNS therapy. The study seeks to improve understanding of why some patients do not respond adequately to HGNS, despite being selected based on strict criteria. By analyzing upper airway mechanics, the study hopes to enhance patient selection and treatment outcomes for those intolerant to CPAP.
Why it matters
Potential benefit: If successful, this study could lead to improved patient selection for HGNS therapy, enhancing treatment outcomes for those with obstructive sleep apnea.
How similar studies have gone: While there have been studies on hypoglossal nerve stimulation, this specific approach focusing on upper airway biomechanics and predictors of response is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male and female participants with moderate or severe sleep apnea (defined by \> 15 apneas and hypopneas per hour of sleep), who are undergoing DISE as part of routine evaluation for Inspire hypoglossal nerve stimulation therapy or for ineffective HGNS therapy. Exclusion Criteria: * Significant cardiac disease, unstable or recent cardiac events * Active pulmonary, liver or renal disease * Uncontrolled hypertension (BP\>160/100) * Neuromuscular disease * Major psychiatric disease * Pregnancy * Anticoagulation therapy (e.g. Coumadin, Dabigatran)
Where it's running
-
Johns Hopkins Hospital
Baltimore, Maryland, United States Recruiting
Study contacts
- Principal investigator: Kevin Motz, MD — Johns Hopkins University
- Study coordinator: Kevin M Motz
- Email: kmotz1@jh.edu
- Phone: 410614245
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI-powered sleep staging and sleep apnea screening using multimodal wearable data
This study tests AI models that use wearable and sensor data to help identify sleep stages and screen for obstructive sleep apnea in adults undergoing standard sleep testing.
-
Jaw advancement with counterclockwise rotation for obstructive sleep apnea
This trial tests whether jaw advancement surgery with counterclockwise rotation helps people with moderate to severe obstructive sleep apnea who can't tolerate CPAP breathe better and sleep more soundly.
-
Eloralintide for people with obstructive sleep apnea who are overweight or obese
This study will test whether the drug eloralintide helps adults with moderate-to-severe obstructive sleep apnea who are overweight or obese, whether they use PAP therapy or not.
-
Long-term use of a nasopharyngeal airway for obstructive sleep apnea
This follow-up lets people who finished the parent trial keep using a nasopharyngeal airway to see how it works over the long term for obstructive sleep apnea.
-
How insomnia affects PAP use in children and teens with obstructive sleep apnea.
This study will see if insomnia makes children and teens with obstructive sleep apnea less likely to stick with positive airway pressure (PAP) therapy.
-
Does mouth opening change with quality of life after adenotonsillectomy in kids with type 1 OSA?
This study tests whether improvements in mouth opening after adenotonsillectomy are linked to better quality of life in children with Type 1 Obstructive Sleep Apnea.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.